Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brad Johnson

Vascular Surgery Tampa, FL Medical Doctor

NPI 1023020302 CMS profile 182716

2 Tampa General Cir, Tampa, FL 33606

Open in the dashboard

General payments

$4,367

90 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brad Johnson of Tampa, FL is reported in the CMS Open Payments database as having received $4,367 across 90 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 47th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $752 15
2024 General $1,181 17
2023 General $888 18
2022 General $547 7
2021 General $226 9
2020 General $176 13
2019 General $597 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brad Johnson
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Brad Johnson were reported at $752. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Brad Johnson Vascular Surgery median Middle half National median
2019 $597 $796 $226–$2,363 $163
2020 $176 $348 $118–$1,110 $114
2021 $226 $471 $158–$1,421 $132
2022 $547 $725 $222–$2,183 $149
2023 $888 $836 $257–$2,440 $160
2024 $1,181 $909 $252–$2,619 $164
2025 $752 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $1,988 35 payments
  2. Cook Medical LLC $1,321 19 payments
  3. Penumbra, Inc. $412 4 payments
  4. Medtronic, Inc. $306 12 payments
  5. Medtronic Vascular, Inc. $176 17 payments
  6. Kerecis Limited $132 1 payment
  7. Integra LifeSciences Corporation $20 1 payment
  8. Pfizer Inc. $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,285 88 payments
  2. Education $50 1 payment
  3. Grant $32 1 payment
Products named General payments · program years 2019–2025
  1. Zenith Spiral-Z $593 10 payments
  2. GORE EXCLUDER AAA Endoprosthesis $455 10 payments
  3. GORE VIABAHN VBX Balloon Expandable Endo $404 5 payments
  4. Zenith $308 4 payments
  5. Penumbra System $285 3 payments
  6. GORE TAG Conformable Thoracic Endoprosthesis $276 4 payments
  7. Endurant $176 17 payments
  8. ENDURANT IIS $164 3 payments
  9. C3 Delivery System $147 1 payment
  10. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $145 1 payment
  11. Other $1,991 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

90 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record